Uniflex Humeral Nail 의 리콜

U.S. Food and Drug Administration에 따르면, 해당 리콜 는 United States 에서 Zimmer Biomet, Inc. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    75229
  • 사례 위험등급
    Class 2
  • 사례 연번
    Z-0087-2017
  • 사례 시작날짜
    2016-08-02
  • 사례 출판 날짜
    2016-10-14
  • 사례 상황
    Terminated
  • 사례 국가
  • 사례 종료 날짜
    2017-03-24
  • 사례 출처
    USFDA
  • 사례 출처 URL
  • 비고 / 경고
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • 데이터 추가 비고
    Pin, fixation, smooth - Product Code HTY
  • 원인
    The g-pin 2.8bl 3.2pl 60 cm 2pk is intended to contain one (1) 467265-01 ball tip guide pin and one (1) 467255-02 plain tip guide pin. the g-pin 2.8bl 3.2pl 60 cm 2pk may have been packaged incorrectly either with two (2) 467265-01 ball tip guide pins and zero (0) 467255-02 plain tip guide pins or with zero (0) 467265-01 ball tip guide pins and two (2) 467255-02 plain tip guide pins. if the g-pin 2.8bl 3.2pl 60 cm 2pk contains the incorrect combination of plain tip guide pins and ball tip guide pins, the surgeon would either have to implant the nail without the plain tip guide pin as a guide, ream with a plain tip guide pin, or choose to not ream the humeral canal. the risk associated with not having the correct combination can include a delay in surgery of less than 30 minutes, the reamer tip remaining in the distal humeral canal, or an iatrogenic fracture.
  • 조치
    The firm, Zimmer Biomet, sent an "URGENT MEDICAL DEVICE RECALL REMOVAL" notification dated 8/2/2016 affected consignees via courier. The recall notification included a description of the reason for the recall, affected product, consignee responsibilities, and instructions for responding to the formal recall notification. The consignees were instructed to review the notification and ensure affected team members are aware of the contents; immediately locate and quarantine affected product in your inventory; complete and return the Certification of Acknowledgment portion of Attachment-1 Inventory Return Certification Form via digital copy within three (3) days via email to CPWARFieldAction@zimmerbiomet.com or via fax to 574-372-1683; Immediately return all affected product from your distributorship and affected hospitals within your territory; and retain a copy of your recall acknowledgement and product return form. If after reviewing this notice you have further questions or concerns please call 1-800-348-9500 ext. 1251 between 8:00 am and 5:00pm EST, Monday through Friday. Calls received outside of business hours will receive a prompt to record a voicemail and will be returned upon receipt. Alternatively, your questions may be sent by email to CPWARFieldAction@zimmerbiomet.com.

Device

  • 모델명 / 제조번호(시리얼번호)
    Item Number 467265 Lot Number 662420
  • 의료기기 분류등급
  • 의료기기 등급
    2
  • 이식된 장치?
    Yes
  • 유통
    US Distribution to states of: MD,TX, FL, GA, VA and PA.
  • 제품 설명
    Uniflex Humeral Nail: 467265 G-PIN 2.8BL 3.2PL 60CM 2PK || Pin, Fixation, Smooth || A 467265-01 Ball Tip Guide Pin is used to guide reamers down the humeral canal during a Uniflex Humeral Nail procedure. A 467255-02 Plain Guide Pin is used to guide a Uniflex Humeral Nail implant into the humeral canal after the fracture has been reduced.
  • Manufacturer

Manufacturer

  • 제조사 주소
    Zimmer Biomet, Inc., 56 E Bell Dr, Warsaw IN 46582-6989
  • 제조사 모회사 (2017)
  • 제조사 의견
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    USFDA